“Our team of researchers at UNSW Sydney have identified a unique set of DNA regions that are altered in ovarian cancer but not in healthy women. We are now in the process of refining our long list of regions to select those with the highest specificity and sensitivity for ovarian cancer. We are achieving this through laboratory assay development to ensure our tests are highly sensitive and accurate, and by collecting blood samples from diverse groups of women (healthy women, women with benign gynaecological diseases such as endometriosis, women with a family history of cancer, women diagnosed with ovarian cancer) to ensure any test we develop is highly specific. The technology behind our test is based on detecting DNA released into the bloodstream and our goal is to develop a blood based early detection test for ovarian cancer.”